News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
lim global
LIM Global, Digital transformation and rebranding by eMascaró
The objectives were clear: communicate the brand's values, encourage customer attraction, entice…
Partners - LIM Global
Ysios Capital anuncia la salida a bolsa en el NASDAQ de su compañía participada CVRx, Inc.
Ysios Capital closes its third fund at €216 million ($260 million)
Ysios BioFund 3 (YBF 3) is the firm’s largest fund to date. To invest in up to 15 companies in…
Partners - Ysios Capital Partners
oryzon
ORYZON to present new clinical data and corporate updates at international conferences in May and June
Healthcare
The conferences are: BioEquity Europe Digital, Foro Medcap BME 2021, Oxford Global’s Online Drug…
Partners - Oryzon Genomics
foto noticia asabys
Asabys Partners certifies with Bureau Veritas its Social Responsibility Management System aligned with the Sustainable Development Goals (SDGs) from United Nations
Financing
Asabys, who has been in business for almost 3 years, has considered sustainability as a fundamental…
Partners - Asabys Partners
edificio oryzon
ORYZON reports results and corporate update for quarter ended March 31, 2021
Healthcare
La compañía invierte 3,6 M€ en I+D sin impactos significativos derivados de la pandemia covid-19
Partners - Oryzon Genomics
3P Facilities
3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new treatment to combat solid tumours
Healthcare · Innovative drugs · Advanced therapies · BioSpain
3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement…
Partners - 3PBIOVIAN
Karen Wagner-min.jpg
Ysios Capital invests in Cytoki Pharma
Financing
Biotech company Cytoki Pharma (Copenhagen, Denmark) develops new proteins based on interleukin 22 (…
Partners - Ysios Capital Partners
Joel Jean Mairet
Ysios Capital leads a 51 million euros investment in Adcendo
Healthcare · Financing
Adcendo (Copenhagen, Denmark), is a biotechnology company specializing in the development of…
Partners - Ysios Capital Partners
Imagen: Chemotargets.
First AI-designed drug for Huntington’s disease to enter clinical trials
In less than 12 months, the collaboration between Chemotargets, based in the Barcelona…
Partners - Parc Científic de Barcelona